DETERMINATION OF MOLECULAR SUBTYPES OF BREAST CANCER IN UZBEKISTAN AND THEIR IMMUNOHISTOCHEMICAL ANALYSIS

Authors

  • Y.Y. Valiyev, G. Ikromova Assistant of the Department of Medical Radiology, Tashkent State Medical University Tashkent, Uzbekistan, ,Student of the Faculty of Medicine at Tashkent State Medical University, Tashkent, Uzbekistan,

DOI:

https://doi.org/10.5281/zenodo.20177348

Keywords:

breast cancer, epidemiology, molecular subtyping, immunotherapy, mutation, oncology, diagnostics, metastasis, screening.

Abstract

 Breast cancer is one of the most common oncological diseases among women worldwide and ranks among the leading causes of cancer-related mortality. This article analyzes the mechanisms of breast cancer development, its etiology, clinical manifestations, risk factors, diagnostic methods, and prevention strategies. It also highlights the importance of early detection and provides information on modern treatment approaches. In recent years, the introduction of genomic testing and targeted therapy has contributed to the development of a personalized approach to disease management.

Downloads

Download data is not yet available.

References

1. World Health Organization. Breast cancer. Fact sheet, 14 August 2025

2. Comparison of Breast Cancer and Cervical Cancer in Uzbekistan and Korea. Mwdicina, 2022(PMC)

3. Global burden and projections of breast cancer incidence and mortality to 2050. Frontiers in Public Health, 20254. International Agency for Research on Cancer. GLOBOCAN 2022:

Uzbekistan Fact Sheet

5. New England Journal of Medicine 344.11

6. Proceedings of the National Academy of Sciences 100.7 (2003)

7. Journal of the Nationl Cancer Institute 90.18

8. American Society of Clinical Oncology. Guidelines on Breast Cancer Biomarkers.

9. Harrison's Principles of Internal Medicine. 21st edition. McGraw-Hill,2022

10. Academy of Pathology, Inc 11.2

11. The American Journal of Human Genetics 69.1

12. World Cancer Report. International Agency for Research on Cancer.

13. Loomes DE, van Znten SV. Bibliometrics of the top 100 clinical articles in digestive disease.

14. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer 2023.

15. Centers for Disease Control and Prevention. Breast cancer statistics and risk factors.2023

Downloads

Published

2026-05-14

Issue

Vol. 5 No. 5 (2026): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

DETERMINATION OF MOLECULAR SUBTYPES OF BREAST CANCER IN UZBEKISTAN AND THEIR IMMUNOHISTOCHEMICAL ANALYSIS. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(5), 967-971. https://doi.org/10.5281/zenodo.20177348

Similar Articles

61-70 of 299

You may also start an advanced similarity search for this article.